Wim Jansen
- LSC 2011 Abstract: Potential anti-inflammatory role of the cAMP effectors Epac and PKA in COPDBy Anouk Oldenburger, Sara Roscioni, Esther Jansen, Mark Menzen, Andrew Halayko, Wim Timens, Herman Meurs, Harm Maarsingh and Martina SchmidtAnouk OldenburgerMolecular Pharmacology, University of Groningen, Groningen, NL Physiology and Internal Medicine, University of Manitoba, Winnipeg, MB, CA Pathology and Medical Biology, University Medical Center Groningen, Groningen, NLSara RoscioniMolecular Pharmacology, University of Groningen, Groningen, NL Physiology and Internal Medicine, University of Manitoba, Winnipeg, MB, CA Pathology and Medical Biology, University Medical Center Groningen, Groningen, NLEsther JansenMolecular Pharmacology, University of Groningen, Groningen, NL Physiology and Internal Medicine, University of Manitoba, Winnipeg, MB, CA Pathology and Medical Biology, University Medical Center Groningen, Groningen, NLMark MenzenMolecular Pharmacology, University of Groningen, Groningen, NL Physiology and Internal Medicine, University of Manitoba, Winnipeg, MB, CA Pathology and Medical Biology, University Medical Center Groningen, Groningen, NLAndrew HalaykoMolecular Pharmacology, University of Groningen, Groningen, NL Physiology and Internal Medicine, University of Manitoba, Winnipeg, MB, CA Pathology and Medical Biology, University Medical Center Groningen, Groningen, NLWim TimensMolecular Pharmacology, University of Groningen, Groningen, NL Physiology and Internal Medicine, University of Manitoba, Winnipeg, MB, CA Pathology and Medical Biology, University Medical Center Groningen, Groningen, NLHerman MeursMolecular Pharmacology, University of Groningen, Groningen, NL Physiology and Internal Medicine, University of Manitoba, Winnipeg, MB, CA Pathology and Medical Biology, University Medical Center Groningen, Groningen, NLHarm MaarsinghMolecular Pharmacology, University of Groningen, Groningen, NL Physiology and Internal Medicine, University of Manitoba, Winnipeg, MB, CA Pathology and Medical Biology, University Medical Center Groningen, Groningen, NLMartina SchmidtMolecular Pharmacology, University of Groningen, Groningen, NL Physiology and Internal Medicine, University of Manitoba, Winnipeg, MB, CA Pathology and Medical Biology, University Medical Center Groningen, Groningen, NL
- Diagnosis of COPD exacerbations on hospital admission: Results from the European COPD auditBy Sylvia Hartl, Jose Lopez-Campos, Mike Roberts, Moniek Haan, Robab Breyer-Kohansal, Wim Jansen, Neven Miculinic, Nikos Tzanakis, Suzanne McCormack, Joanna Chorostowska, Ivan Solovic, Francisco Pozo-Rodríguez, Daiana Stolz, Mehmet Polati, Sally Welham, Cynthia Farrugia Jones and Florin MihaltanSylvia Hartl1Dep.Resp.and Critical Care, Otto Wagner Hospital and Ludwig Boltzmann Institute of COPD and Resp. Epidemiology, Vienna, AustriaJose Lopez-Campos2Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Hospital Universitario Virgen del Rocio, Sevilla, SpainMike Roberts3Clinical Effectiveness and Evaluation Unit, Royal College of Physicians, London, United KingdomMoniek Haan4ERS School, European Respiratory Society, Lausanne, SwitzerlandRobab Breyer-Kohansal1Dep.Resp.and Critical Care, Otto Wagner Hospital and Ludwig Boltzmann Institute of COPD and Resp. Epidemiology, Vienna, AustriaWim Jansen5Dept. Resp. and Critical Care, Universitaire Ziekenhuizen Leuven, Leuven, BelgiumNeven Miculinic6Dept. Resp. Medicine, Clinic for Lung Diseases Jordanovac, Zagreb, CroatiaNikos Tzanakis15British Thoracic Society, British Thoracic Society, London, United KingdomSuzanne McCormack8Irish Thoracic Society, Dublin, IrelandJoanna Chorostowska9Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsawa, PolandIvan Solovic10Dept. of Resp Diseases, National Institute for TB, Lung Diseases and Thoracic Surgery Vysne Hagy, Catholic University, Vysne Hagy, Slovakia (Slovak Republic)Francisco Pozo-Rodríguez11Dept. of Respiratory Medicine and Clinical Epidemiology Unit, University Hospital 12 de Octubre, Madrid, SpainDaiana Stolz12Clinic of Pneumology and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandMehmet Polati13Dept. of Resp. Diseases, Menderes Universitesi Tip, Aydin, TurkeySally Welham15British Thoracic Society, British Thoracic Society, London, United KingdomCynthia Farrugia Jones7Dept. Resp. Medicine, Mater Dei Hospital, Marsaxlo, MaltaFlorin Mihaltan14Dept of Pneumology, University of Bucharest, Bucharest, Romania
- Provision of nonpharmacolocical treatment options for COPD patients in 13 European countries: Results from the European COPD auditBy Sylvia Hartl, Jose Lopez-Campos, Mike Roberts, Moniek Haan, Robab Breyer-Kohansal, Wim Jansen, Neven Miculinic, Nikos Tzanakis, Suzanne McCormack, Joanna Chorostowska, Ivan Solovic, Francisco Pozo-Rodríguez, Daiana Stolz, Mehmet Polatli, Sally Welham, Cynthia Farrugia Jones and Florin MihaltanSylvia Hartl1Dep.Resp.and Critical Care, Otto Wagner Hospital and Ludwig Boltzmann Institute of COPD and Resp. Epidemiology, Vienna, AustriaJose Lopez-Campos2Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Hospital Universitario Virgen del Rocio, Sevilla, SpainMike Roberts3Clinical Effectiveness and Evaluation Unit, Royal College of Physicians, London, United KingdomMoniek Haan4ERS School, European Respiratory Society, Lausanne, SwitzerlandRobab Breyer-Kohansal1Dep.Resp.and Critical Care, Otto Wagner Hospital and Ludwig Boltzmann Institute of COPD and Resp. Epidemiology, Vienna, AustriaWim Jansen5Dep.resp. and Critical Care, Universitaire Ziekenhuizen Leuven, Leuven, BelgiumNeven Miculinic6Dep.resp. Medicine, Clinic for Lung Diseases Jordanovac, Zagreb, CroatiaNikos Tzanakis8Department of Thoracic Medicine, University of Crete, Crete, GreeceSuzanne McCormack9Irish Thoracic Society, Dublin, IrelandJoanna Chorostowska10Laboratory of Molecular Diagnostics and Immunology, National Institute of Tuberculosis and Lung Diseases, Warsawa, PolandIvan Solovic11Dept. of Resp Diseases, National Institute for TB, Lung Diseases and Thoracic Surgery Vysne Hagy, Catholic University, Vysne Hagy, Slovakia (Slovak Republic)Francisco Pozo-Rodríguez12Dep.of Respiratory Medicine and Clinical Epidemiology Unit, University Hospital 12 de Octubre, Madrid, SpainDaiana Stolz13Clinic of Pneumology and Respiratory Cell Research, University Hospital Basel, Basel, SwitzerlandMehmet Polatli14Dep. of Resp. Diseases, Menderes Universitesi Tip, Aydin, TurkeySally Welham16British Thoracic Society, British Thoracic Society, London, United KingdomCynthia Farrugia Jones7Dep.Resp. Medicine, Mater Dei Hospital, Marsaxlo, MaltaFlorin Mihaltan15Dept of Pneumology, University of Bucharest, Bucharest, Romania
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
